Swiss drug giant Novartis bought the biotech for $9 billion last year in part because AveXis had figured out how to actually make gene therapies at a ...
News
- The top scientist at AveXis told us the 'unique' strength that powered its $9 billion sale to Novartis ...
- Want Your Seed-Stage Startup to Be Fundable? Check These 4 Boxes.
Aside from a few rare situations in biotech or hardware in which new tech occasionally merits funding on its own, VC investable deals tend to need ...
- KCU Joplin to share research lab with Missouri Southern
JOPLIN, Mo. (AP) — The Kansas City University of Medicine and Biosciences is planning to open a laboratory at Missouri Southern State University in ...
- EXCLUSIVE: Economic impact study will measure size, strength, of Valley's healthcare industry
The study found Healthcare and Bioscience to be one of San Antonio's largest industries. Its economic impact in 2017 was $30.6 billion measured ...
- Argo Group International Holdings LTD. (NYSE:ARGO) Sellers Strengthened By 0.2% Their Shorts ...
... investor targets Argo Group over CEO spending – San Antonio Business Journal” with a publish date: February 25, ... and Moleculin Biotech — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” ...